{"id":96429,"date":"2019-09-19T13:22:28","date_gmt":"2019-09-19T20:22:28","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/09\/two-drug-combo-more-effective-at-lowering-blood-sugar-in-diabetes-patients"},"modified":"2019-09-19T13:22:28","modified_gmt":"2019-09-19T20:22:28","slug":"two-drug-combo-more-effective-at-lowering-blood-sugar-in-diabetes-patients","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/09\/two-drug-combo-more-effective-at-lowering-blood-sugar-in-diabetes-patients","title":{"rendered":"Two-drug combo more effective at lowering blood sugar in diabetes patients"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/two-drug-combo-more-effective-at-lowering-blood-sugar-in-diabetes-patients.jpg\"><\/a><\/p>\n<p>Sept. 18 (UPI) \u2014 When it comes to controlling early symptoms of type 2 diabetes, two drugs are better than one, a new study says.<\/p>\n<p>Prescribing metformin and vildagliptin to people newly diagnosed with type 2 diabetes reduced their long-term blood sugar levels more than single-drug therapy, according to <a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(19)32131-2\/fulltext\" target=\"_blank\">findings published Wednesday<\/a> in The Lancet. The patients also had lower rates of treatment failure than those who only used Metformin, the current first-line drug used by new type 2 diabetics.<\/p>\n<p>\u201cThe findings of VERIFY support and emphasize the importance of achieving and maintaining early glycaemic control,\u201d the authors wrote.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sept. 18 (UPI) \u2014 When it comes to controlling early symptoms of type 2 diabetes, two drugs are better than one, a new study says. Prescribing metformin and vildagliptin to people newly diagnosed with type 2 diabetes reduced their long-term blood sugar levels more than single-drug therapy, according to findings published Wednesday in The Lancet. [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-96429","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/96429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=96429"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/96429\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=96429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=96429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=96429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}